Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1350 of 2873 entries
View as:

Phase II Study of Pazopanib and Topotecan in Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02348398 Org: User:
Start: 08/31/16 End: - Due: -

Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00469014 Org: User:
Start: 09/30/06 End: 03/31/13 Due: 03/31/14

ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter

Phase: N/A Priority: Normal
NCT ID: NCT04668833 Org: User:
Start: 09/29/20 End: 02/02/27 Due: 02/02/28

Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03428126 Org: User:
Start: 03/21/18 End: 05/05/22 Due: 05/05/23

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Phase: N/A Priority: Normal
NCT ID: NCT00960752 Org: User:
Start: 05/20/10 End: 07/20/20 Due: 07/20/21

CFAR Study in Patients With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00525603 Org: User:
Start: 06/30/05 End: 07/31/11 Due: 07/31/12

Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03290937 Org: User:
Start: 12/27/17 End: 12/31/26 Due: 12/31/27

Acalabrutinib and Rituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04765111 Org: User:
Start: 06/30/21 End: 08/30/26 Due: 08/30/27

Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02703623 Org: User:
Start: 05/18/16 End: 03/31/26 Due: 03/31/27

Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00903006 Org: User:
Start: 11/30/09 End: 05/31/13 Due: 05/31/14

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03175432 Org: User:
Start: 06/15/17 End: 06/30/26 Due: 06/30/27

Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00101010 Org: User:
Start: 09/30/05 End: 09/30/14 Due: 09/30/15

Ask Advise Connect (AAC) Harris Heath CPRIT

Phase: N/A Priority: Normal
NCT ID: NCT01788787 Org: User:
Start: 04/30/13 End: 04/30/49 Due: 04/30/50

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04181463 Org: User:
Start: 11/05/25 End: 12/30/25 Due: 12/30/26

Molecular Epidemiology of Biliary Tree Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05179486 Org: User:
Start: 09/25/17 End: 02/02/27 Due: 02/02/28

STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT05519527 Org: User:
Start: 08/16/22 End: 02/15/23 Due: 02/15/24

Endobronchial Ultrasound Versus Mediastinoscopy in Patients With Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00559611 Org: User:
Start: 10/19/07 End: 03/22/18 Due: 03/22/19

Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

Phase: N/A Priority: Normal
NCT ID: NCT04474301 Org: User:
Start: 06/11/20 End: 12/30/26 Due: 12/30/27

Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04555577 Org: User:
Start: 09/20/20 End: 10/30/25 Due: 10/30/26

A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder

Phase: N/A Priority: Normal
NCT ID: NCT05137262 Org: User:
Start: 10/13/21 End: 08/31/26 Due: 08/31/27

Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas

Phase: N/A Priority: Normal
NCT ID: NCT04701307 Org: User:
Start: 02/01/21 End: 11/30/25 Due: 11/30/26

Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2

Phase: N/A Priority: Normal
NCT ID: NCT03048279 Org: User:
Start: 09/05/01 End: 09/01/26 Due: 09/01/27

Effects of Social Networking on Chronic Disease Management in Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02717403 Org: User:
Start: 04/07/16 End: 06/07/23 Due: 06/07/24

Chlorhexidine Gel Therapy for Cariogenic Oral Microflora

Phase: N/A Priority: Normal
NCT ID: NCT01036412 Org: User:
Start: 12/31/09 End: 08/31/12 Due: 08/31/13

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04754425 Org: User:
Start: 07/15/21 End: 06/30/26 Due: 06/30/27